News – OpenSpecimen

Understanding the value of biobank attributes to researchers using a conjoint experiment

rashmi — Mon, 24 Aug 2026 05:21:18 +0000

Biobanks are important in biomedical and public health research, and future healthcare research relies on their strength and capacity. However, there are financial challenges related to the operation of commercial biobanks and concerns around the commercialization of biobanks. Non-commercial biobanks depend on grant funding to operate and could be valuable to researchers if they can enable access to quality specimens at lower costs. The objective of this study is to estimate the value of specific biobank attributes. We used a rating-based conjoint experiment approach to study how researchers valued handling fee, access, quality, characterization, breadth of consent, access to key endemics, and time taken to fulfil requests. We found that researchers placed the greatest relative importance on the quality of specimens (26%), followed by the characterization of specimens (21%). Researchers with prior experience purchasing biological samples also valued access to key endemic in-country sites (11.6%) and low handling fees (5.5%) in biobanks.

This paper was published by Dr Deepshikha Batheja and her team in Nature Scientific Reports.

For the full article: https://doi.org/10.1038/s41598-023-49394-6

Biobanks in veterinary forensic medicine: A systematic review on Advances, challenges, and applications in combating wildlife trafficking

rashmi — Thu, 20 Aug 2026 05:05:31 +0000

Background and Aim: Biobanks represent organized repositories of biological samples linked to associated data, designed for long-term scientific, clinical, and forensic utilization. In veterinary medicine, animal biobanks facilitate biomedical research, genetic resource preservation, species conservation, and forensic investigations. The present systematic review aimed to synthesize advances, persistent challenges, and practical applications of biobanks in veterinary forensic medicine, with particular emphasis on their contribution to detection, investigation, and suppression of wildlife trafficking.

Results: Of 1,495 records identified, 15 studies fulfilled all inclusion criteria after exclusion of 1,460 irrelevant or non-qualifying publications. No eligible articles appeared between 2013 and 2014. From 2015 onward, publications demonstrated progressive refinement, transitioning from molecular barcoding for species identification toward integrated applications in geographic origin assignment, chain-of-custody documentation, and evidentiary support in judicial proceedings. Key materials included DNA from muscle, scales, claws, and feathers; cryopreserved gonadal tissues; and somatic cells derived from minimally invasive sources (e.g., feather follicles) or roadkill specimens. Studies highlighted particular utility in identifying fraudulently labeled fishery products, counterfeit mammalian derivatives (e.g., fake tiger claws), and confiscated pangolin scales, as well as in tracing trafficking routes in high biodiversity regions.

Conclusion: Veterinary forensic biobanks offer substantial potential for accurate species and geographic provenance determination, thereby strengthening enforcement against illegal wildlife trade. Nevertheless, implementation remains constrained by absent standardized operating procedures, limited practitioner awareness, fragmented reference databases, inadequate inter-institutional connectivity, and elevated logistic/financial demands. Regionalized biobanks integrated with wildlife screening centers (CETAS), harmonized chain-of-custody protocols, and artificial intelligence-supported data curation are proposed as priority strategies to translate existing scientific advances into routine forensic and conservation practice.

This paper was published in Veterinary World by the team of Natália Freitas de Souza under the guidance of Noeme Sousa Rocha

Source: 10.14202/vetworld.2026.933-947

Quality matters: International standards for biobanking

rashmi — Mon, 10 Aug 2026 09:56:43 +0000

Human biospecimens provide the basis for research, leading to a better understanding of human disease biology and discovery of new treatments that are tailored to individual patients with cancer or other common complex diseases. The collection, processing, preservation, storage, and providing access to these resources are key activities of biobanks. Biobanks must ensure proper quality of samples and data, ethical and legal compliance, as well as transparent and efficient access procedures. The standards for biobanking outlined herein are intended to be implemented in biobanks and to supply researchers with high-quality samples fitted for an intended use.

This paper was published in Cell Proliferation by Georges Dagher, Emeritus Research Director at Inserm, Paris.

https://doi.org/10.1111/cpr.13282

How Marine Cryopreservation Is Pausing Extinction for Ocean Life

Prathamesh Sontakke — Thu, 30 Jul 2026 04:41:15 +0000

Abstract: As climate change alters ocean chemistry faster than species can adapt, marine scientists are turning to cryogenic biobanks as both a biological record and an ecological insurance policy. While maintaining living cultures in lab bottles allows organisms to continuously adapt and evolve away from their natural state, ultra-low temperature cryopreservation literally “stops time”. By locking gametes, microalgae, and tissue samples in liquid nitrogen tanks at sub-zero temperatures, researchers preserve exact genetic snapshots of marine organisms as they existed in the wild, safeguarding biodiversity against rising ocean temperatures.

This frozen archive is moving directly into active ecosystem restoration through breakthroughs like “coral IVF”. In regions where coral populations have become too sparse to fertilise naturally, scientists are using cryopreserved sperm and heat-resilient algae to cross-breed and reseed dying reefs in the Caribbean and Pacific. However, marine biobanking also introduces complex questions around preserving entire symbiotic microbiomes rather than isolated species, while navigating ethical rights and indigenous connections to “sea country” when living heritage is stored hundreds of miles away in a freezer.

Read the full article here: https://www.modernghana.com/news/1505970/marine-biobanks-the-science-of-stopping-time.html

How Biobanks Reveal Ongoing Natural Selection in Humans

Prathamesh Sontakke — Tue, 28 Jul 2026 05:57:56 +0000

Abstract: While biobanks are traditionally designed to advance precision medicine, a landmark study in The American Journal of Human Genetics proves they are also powerful tools for studying modern human evolution. By analyzing allele frequency shifts across age groups in over 72,000 Han Taiwanese participants, researchers uncovered 168 genetic variants showing clear signs of ongoing natural selection, with roughly 90% being rare variants that standard genomic scans typically miss. These findings demonstrate that human populations are actively evolving, offering critical insights into how selective pressures continue to shape disease susceptibility.

The study revealed complex evolutionary trade-offs across critical DNA repair genes like BRCA1, BRCA2, and MLH1, where purifying and positive selection act side-by-side. Researchers also identified pleiotropic genes such as ATG9A and FADS2 affecting cardiovascular, liver, and kidney functions, alongside 150 red blood cell variants tied to historical malaria adaptation in Taiwan. Applying this age-stratified biobank framework globally will help bridge non-European genomic gaps, transforming how we understand human diversity and disease risk.

Read the full article here: https://www.biocompare.com/Life-Science-News/627060-Large-Biobanks-Reveal-Signs-of-Ongoing-Natural-Selection-in-Humans/

How Next-Gen Biobanks Are Revolutionizing Precision Medicine

Prathamesh Sontakke — Thu, 23 Jul 2026 04:35:59 +0000

Abstract: Modern biobanks are rapidly evolving from static storage facilities into dynamic, AI-driven digital ecosystems. By pairing deep longitudinal electronic health records with multiomic data, large-scale repositories like the UK Biobank and Singapore’s PRECISE-SG100K are shifting research away from isolated snapshots of health. This scale enables scientists to track complex disease progression across vast populations, turning raw biological data into reproducible, real-world clinical impact.

While genomics reveals our static baseline risk, proteomics captures real-time physiological shifts, making it a critical tool for early disease detection. Recent studies demonstrate that analyzing thousands of circulating proteins can identify early biological markers of cancer up to 7 years before clinical symptoms appear. Coupled with AI-driven analytics, standardized collection protocols, and diverse population cohorts, next-generation biobanks are laying the groundwork for earlier diagnostics, precise patient stratification, and accelerated drug discovery.

Get the full article here: https://www.technologynetworks.com/proteomics/articles/biobanks-proteomics-and-ai-converge-to-advance-precision-medicine-414413

Cellular Clocks: How Accelerated Aging is Driving Cancers in Younger Adults

Prathamesh Sontakke — Tue, 21 Jul 2026 09:50:29 +0000

Abstract: For decades, cancer was considered a disease that primarily affected older adults after a lifetime of cellular wear and tear. However, a groundbreaking study published in Nature Medicine reveals a concerning new trend: younger generations are aging biologically faster than previous generations did at the same chronological age. By analyzing health data and standard blood markers from over 160,000 participants in the UK Biobank and the U.S. All of Us Research Program, researchers calculated an “age gap” comparing a person’s actual age to their biological cellular health. The findings showed that adults born in the 1990s have a significantly higher biological age gap than those born in the 1960s, providing a clear biological link to why early-onset cancers have risen sharply over the past decade.

This accelerated cellular aging carries direct health consequences, with every step increase in the biological age gap tied to an eight percent higher risk of developing early-onset solid cancers. The strongest associations were found in lung, gastrointestinal, and uterine tissues, driven largely by modern lifestyle stressors like ultra-processed diets, physical inactivity, and environmental toxin exposures. Fortunately, biobanks are helping researchers turn these insights into action by demonstrating how routine blood tests can track biological age. By identifying young adults whose cells are aging prematurely, clinicians can move away from one-size-fits-all screening guidelines and implement targeted, early interventions long before tumors can develop.

Get the full article here: https://www.medicalbrief.co.za/rapid-ageing-in-young-adults-tied-to-hike-in-cancer-rates-us-study/

Why South Asia Urgently Needs Integrated Biobanks

Prathamesh Sontakke — Thu, 16 Jul 2026 04:55:48 +0000

Abstract: Large-scale, integrated biobanks like the UK Biobank have completely revolutionized modern healthcare research by linking massive genetic databases with electronic health records. Unfortunately, a major blind spot persists in global biomedical discovery: despite representing a quarter of the world’s population, South Asia accounts for a mere 0.2% of participants in global genome-wide association studies. When regional scientists attempt to research widespread chronic conditions like diabetes, they are forced to work with small, fragmented institutional datasets or rely heavily on data derived from non-South Asian populations. This severe lack of representation means that as the global revolution in precision medicine moves forward, nearly two billion people risk being left behind with medical solutions that were never designed for their unique genetic background.

To dismantle this disparity, public health experts are proposing the establishment of a federated South Asia Biobank Consortium. Rather than forcing a single, rigid cross-border project, this model advocates for coordinated national biobanks that use harmonized sample protocols while utilizing advanced federated analytics to allow cross-border research without moving raw patient data across sensitive national boundaries. This technical blueprint protects national data sovereignty while simultaneously scaling up the region’s immense statistical power to track rare diseases and environmental exposures. Backed by culturally adaptive consent models, community advisory boards, and strict data-privacy layers, this coordinated initiative will transform South Asia from a peripheral participant into a powerful global engine for medical equity and life-saving scientific discovery.

Sounds Interesting? Read the full article here: https://www.sciencedirect.com/science/article/pii/S2772368226000624

Cracking the Dietary Code: How Biobanks and AI Partner to Drive Precision Nutrition

Prathamesh Sontakke — Tue, 14 Jul 2026 04:59:57 +0000

Abstract: Dietary factors represent a critical, highly modifiable lever for global health, yet traditional “one-size-fits-all” food guidelines consistently fail to account for how differently individual bodies react to the same meals. To solve this problem, the medical community is moving toward Precision Nutrition (PN) by leveraging massive, multi-omic repositories like the UK Biobank and the All of Us Research Program. By feeding advanced artificial intelligence (AI) and tree-based machine learning models a deep mix of genetic profiles, clinical biomarkers, and lifestyle data extracted from these biobanks, researchers can finally map out unique metabolic patterns. In fact, large cohort studies show that when gradient-boosted trees integrate a participant’s specific gut microbiome sequence with their clinical history, the algorithms can accurately forecast postprandial glycemic spikes, proving that our ideal diets are completely personal.

However, building these customized nutrition models is incredibly challenging because biobank datasets feature diverse data layers that are episodic, context-dependent, and highly prone to self-reporting errors. Merging high-frequency wearable time series, like continuous glucose monitors, with snapshot food questionnaires introduces major statistical noise and incompatible measurement standards that can easily cause standard AI algorithms to overfit the data. To overcome these complex hurdles, data scientists are introducing strict cross-layer harmonization standards, unified phylogenetic references, and specialized tools like Graph Neural Networks to map structural interactions between microbes and metabolites. By moving past generic algorithms and implementing these nutrition-specific best practices, the scientific community is building an auditable, data-driven pipeline capable of turning raw biobank specimens into safe, actionable dietary interventions.

Sounds Interesting? Read the full article here: https://www.nature.com/articles/s41467-026-75004-w#Abs1

Outsmarting Cancer: How Tumors Change Their Fuel to Survive Treatment

Prathamesh Sontakke — Thu, 09 Jul 2026 06:05:20 +0000

Abstract: Cancer is incredibly resilient, and a large part of its survival comes down to a superpower known as “metabolic flexibility.” Just like a hybrid car that can switch between electricity and gasoline, tumor cells can seamlessly swap their fuel sources depending on what is available in their environment. Whether they consume glucose, amino acids, or metabolic byproducts like lactate, this adaptability allows cancer cells to thrive even in harsh, low-oxygen zones where normal cells would perish. Alarmingly, this flexibility also serves as a major shield against standard treatments; when a specific drug cuts off one energy pathway, the tumor simply adapts by activating a backup route to stay alive.

To break this defensive loop, scientists are exploring “precision nutrition” strategies that aim to starve cancer of its preferred fuel sources. For instance, ketogenic diets, which are very low in carbohydrates, aim to drastically lower blood sugar and insulin levels, making it harder for highly glucose-dependent tumors to multiply. Similarly, short-term dietary restrictions targeting specific amino acids, like arginine or methionine, are being tested to exploit genetic weaknesses in certain cancers. While these diets are not standalone cures, combining them with targeted therapies shows massive promise in preclinical trials, opening up a future where a patient’s customized menu works hand-in-hand with their medical treatment to defeat resistance.

Read this full article here: https://www.news-medical.net/health/Metabolic-Flexibility-in-Cancer-How-Diet-and-Nutrition-Shape-Tumor-Survival-and-Resistance.aspx